Meghan Markle, Britain’s Duchess of Sussex, says she is now “ready to talk” along with husband Prince Harry, ahead of a highly anticipated weekend airing of an interview with Oprah Winfrey.Markle credits her newfound freedom for opening up about the limitations put on her by the royal family and her appreciation for making her own decisions.”It’s really liberating to be able to have the right and the privilege in some ways to be able to say, ‘Yes … I’m ready to talk,’ ” she said.Markle believes now is the time to share her side of the story and how life has changed since leaving the royal family.“We’re on the other side of a lot of, a lot of life experience that’s happened,” Markle said. “And also that we have the ability to make our own choices in a way that I couldn’t have said yes to you then, that wasn’t my choice to make.”Markle and Prince Harry, who tied the knot in May 2018, stunned the royal family in January when they announced they would step down from their official royal duties to live independently in Montecito, California.Since coming to Montecito, the couple announced their new commonwealth project, Archewell Foundation, named after their son Archie. Teaming with chef José Andrés’ World Central Kitchen, the foundation said it would create Community Relief Centers in regions of the world prone to climate disasters.Sunday’s interview comes after Buckingham Palace announced Wednesday it would be launching an investigation into claims Markle bullied her staff while still living as a royal in London.“I don’t know how they could expect that after all of this time, we would still just be silent if there is an active role that the firm is playing in perpetuating falsehoods about us,” Markle said.Oprah with Meghan and Harry will air this Sunday at 8 p.m. EST on the CBS television network.
…
Day: March 5, 2021
The White House COVID-19 response team said Friday that all coronavirus vaccines currently available were safe and effective and urged Americans to take whichever one they had access to, after the mayor of Detroit reportedly declined an allocation of the Johnson & Johnson drug.At a news briefing Thursday, Detroit Mayor Mike Duggan said he was declining a shipment of the Johnson & Johnson vaccine, adding that while it was a very good vaccine, he felt the Pfizer-BioNTech and Moderna vaccines were better and he wanted to get the people of Detroit “the best.”At a virtual news briefing Friday, coronavirus special adviser Andy Slavitt said that the White House reached out to the mayor and that there had been a misunderstanding. It was not Duggan’s intent to refuse the vaccine, said Slavitt, adding, “In fact, he is very eager for the Johnson & Johnson vaccine.”National Institutes of Health infectious-disease expert Dr. Anthony Fauci again said that all three approved vaccines were “extraordinarily” effective in preventing severe disease and death. He advised taking the first available vaccine because the important thing is to be vaccinated.Meanwhile, Centers for Disease Control Director Dr. Rochelle Walensky said the agency hoped to release its official guidance for people who have been fully vaccinated. She said she understood people were eager to know what they could and couldn’t do, but that the centers wanted to make sure to get the advice right.The CDC guidelines would address a myriad of questions regarding approved activities, such as wearing a mask, flying on an airplane, or patronizing a bar or restaurant.More than 54 million people in the U.S. have received at least one shot; more than 27 million Americans are fully vaccinated.
…
The World Health Organization says it is using every measure it has to curb the spread of parallel Ebola outbreaks in Guinea and the Democratic Republic of Congo. One of the biggest lessons learned from the 2014-2016 Ebola epidemic in West Africa — the largest in history — is the critical importance of acting quickly to contain the deadly disease. World health officials began marshaling staff and working on a strategy to combat the disease as soon as the first cases of the Ebola virus were detected in Guinea on February 14. A rapid assessment conducted by the WHO in the country and in the region found the risk level to be very high. WHO Representative in Guinea, Georges Alfred Ki-Zerbo, said the WHO and partners have been stepping up efforts to implement Guinea’s Strategic response plan. FILE – Health workers from the Guinean Ministry of Health prepare forms to register medical staff ahead of their anti-Ebola vaccines at the N’zerekore Hospital, Feb. 24, 2021.That, he said, involves increased surveillance on the ground, accelerating preparedness measures in neighboring countries, and working closely with communities to interrupt the outbreak as soon as possible. “In doing so, we are engaging traditional healers, including also traditional practitioners, and we are going into communities to discuss with them, to listen to them and see what is the understanding of the disease, what is the fears and the preoccupation of the communities so that we can increase the success of our interventions,” Ki-Zerbo said. To date, the WHO reports 18 cases of Ebola in Guinea, including four deaths. Ki-Zerbo said health workers have traced hundreds of people who have come in contact with infected people. So far, he ssaid, more than 1,600 people have been vaccinated against the virus, including high-risk contacts and health workers. Meanwhile, North Kivu province in eastern Congo is experiencing its own fresh Ebola outbreak. Since February 7, the WHO reports there have been 11 cases and four deaths. Another Ebola outbreak in eastern Congo ended just last June. WHO director of strategic health operations, Michel Yao, said dealing with both the COVID-19 and Ebola epidemics is a challenge, especially in countries with fragile health systems. “There are some similar approaches, at least, in some of the components like community isolation, as well as the preventive measures that have to be implemented,” Yao said. “Vaccination is maybe less challenging because this works in different areas. And I think the approach in most of the countries, as with COVID, they will probably start with health workers.” WHO health officials agree it will likely be difficult to get the funding needed to stem the twin Ebola outbreaks. Besides appealing to government donors, they said they also will tap leading financial institutions such as the World Bank, the African Development Bank and the U.S. Agency for International Development.
…
A Wall Street Journal report says World Health Organization investigators who recently visited China to determine the origins of the emergence of the COVID-19 virus will not release a promised interim report of their findings.The Journal account, published Thursday, said the WHO team decided not to release its interim account “amid mounting tensions between Beijing and Washington.” Another international group of scientists has called for the WHO to conduct a new inquiry into COVID’s origins.The scientists calling for a new probe said in an open letter Thursday that the WHO team “did not have the mandate, the independence, or the necessary accesses to carry out a full and unrestricted investigation.”The scientists also noted in their letter that the WHO investigators in China were joined by their Chinese counterparts.A report in The Guardian says hospitals in Papua New Guinea have run out of money and are “shutting their doors” because of an uptick in COVID-19 cases. The country had registered 124 new coronavirus cases in all of February but had 108 new infections by March 4.The U.S. Food and Drug Administration issued a public warning Thursday about thermal imaging devices or scanners used by many businesses to measure elevated temperature, a COVID symptom.The FDA alert said, “improper use of the systems may provide inaccurate temperature readings due to a variety of factors.” The agency also said it has sent “several Warning Letters” to companies that are “offering unapproved, uncleared, and unauthorized thermal imaging systems for sale.Auckland, New Zealand, is set to ease its seven-day lockdown on Sunday, moving from alert level three to alert level two because no new community coronavirus cases were recorded Friday. The rest of the country is scheduled to move to alert level one Sunday.Johns Hopkins Coronavirus Resource Center said early Friday there are more than 115 million global COVID cases. The U.S. remains at the top of the list with almost 29 million infections, followed by India with 11 million and Brazil with 10.7 million.
…
U.S. President Joe Biden’s order to secure semiconductor supply chains for high-tech hardware production offers a commercial boost to Taiwan, one of the world’s biggest providers of chips, and gives Taipei new weight in any free-trade talks, analysts say.Biden signed an executive order Feb. 24 for the United States to start overcoming a chip shortage that has hobbled the manufacturing of vehicles, consumer electronics and medical supplies. It will trigger a review process leading to policy recommendations on how to bolster supply chains.Taiwan comes into play as the home of Taiwan Semiconductor Manufacturing Co., which spins out more chips than any other contract manufacturer in the world and has some of the most advanced production processes. Those advances generate semiconductors that run on relatively little power without sacrificing the speed of a device.Remote study and telework, two trends that exploded during the 2020 coronavirus outbreak, raised demand last year for chips that run notebook PCs, among other types of consumer hardware. World demand for chips should increase from $450 billion last year to about $600 billion in 2024, market research firm Gartner says.“This is good, and I think at this moment Taiwan finally can offer something concretely and to help the United States somehow, some way,” said Liu Yih-jiun, public affairs professor at Fo Guang University in Taiwan.Taiwan has tried off and on since 1994 to arrange a trade deal with the United States, which is its second-biggest trading partner after China. U.S.-Taiwan trade totaled $90.9 billion in 2020. Americans buy chips, computers and machinery, among other Taiwanese goods, resulting in a $29.3 billion trade surplus for the Asian manufacturing center last year.Starting in January, Taiwan began allowing shipments of American pork from pigs raised on the feed additive ractopamine, and U.S. officials lauded that step as progress in trade relations.The Biden administration has asked Taiwanese officials about pushing their chipmakers to step up semiconductor production amid a shortage of chips for automotive use, Bloomberg reported last month.American demand for semiconductors will help raise Taiwan’s position when negotiators meet again for trade talks, said John Brebeck, senior adviser at the Quantum International Corp. investment consultancy in Taipei.“Because of the [Sino-U.S.] trade war, and because of semiconductors, and because Taiwan did so well on COVID, and it’s a democracy they want to support, I think it moves forward,” Brebeck said.Trade talks will take place “in a much more balanced way” due to Taiwan’s weight in global semiconductors, Liu said.Trade deal or not, Taiwan’s chipmakers will get a surge in business because of the shortage, though they may struggle to prioritize customers, Brady Wang, an analyst in Taipei with the market intelligence firm Counterpoint Research, said.“There’s actually no risk to the companies, but you can say there’s the issue of how much they can spread out production and who they’re going to sacrifice,” Wang said.Taiwan Semiconductor Manufacturing Co. broke ground in 2018 on a $15 billion factory complex in Taiwan with volume production expected to reach full capacity this year. The complex will produce more than 1 million wafers per year and employ about 4,000 people. In December last year the 34-year-old firm got Taiwan government clearance to build a $12 billion factory in the U.S. state of Arizona. That plant will make up to 20,000 wafers per month.The project in Arizona and the new one in Taiwan are “well on track,” a spokesperson from the company’s headquarters said.Powerchip Semiconductor Manufacturing Corp. and United Microelectronics Corp. also make chips in Taiwan. A spokesperson for United Microelectronics said last month his company was doing all it can to meet demand for automotive chips.
…
A Wall Street Journal report says World Health Organization investigators who recently visited China to determine the origins of the emergence of the COVID-19 virus will not release a promised interim report of their findings.The Journal account, published Thursday, said the WHO team decided not to release its interim account “amid mounting tensions between Beijing and Washington.” Another international group of scientists has called for the WHO to conduct a new inquiry into COVID’s origins.The scientists calling for a new probe said in an open letter Thursday that the WHO team “did not have the mandate, the independence, or the necessary accesses to carry out a full and unrestricted investigation.”The scientists also noted in their letter that the WHO investigators in China were joined by their Chinese counterparts.A report in The Guardian says hospitals in Papua New Guinea have run out of money and are “shutting their doors” because of an uptick in COVID-19 cases. The country had registered 124 new coronavirus cases in all of February but had 108 new infections by March 4.The U.S. Food and Drug Administration issued a public warning Thursday about thermal imaging devices or scanners used by many businesses to measure elevated temperature, a COVID symptom.The FDA alert said, “improper use of the systems may provide inaccurate temperature readings due to a variety of factors.” The agency also said it has sent “several Warning Letters” to companies that are “offering unapproved, uncleared, and unauthorized thermal imaging systems for sale.Auckland, New Zealand, is set to ease its seven-day lockdown on Sunday, moving from alert level three to alert level two because no new community coronavirus cases were recorded Friday. The rest of the country is scheduled to move to alert level one Sunday.Johns Hopkins Coronavirus Resource Center said early Friday there are more than 115 million global COVID cases. The U.S. remains at the top of the list with almost 29 million infections, followed by India with 11 million and Brazil with 10.7 million.
…
This week a U.S.-government backed commission of technology experts completed a three-year review of the country’s artificial intelligence capabilities, urging the development of a new national technology strategy to stay competitive with China.The National Security Commission on Artificial Intelligence (NSCAI) has been studying how artificial intelligence and machine learning can address U.S. national security and defense needs. It recommended spending billions of dollars more on research, diversifying the American industrial supply chain for microchips and other high-tech products, and reforming immigration policies to attract talented researchers and workers.Some of those steps are under way. Republican and Democratic lawmakers are now focusing more on ways to address technological competition with China, following years in which officials say China carried out corporate espionage and forced technology transfers to rapidly advance its technological capabilities.Sen. Mark Warner, D-Va., talks to reporters on Jan. 28, 2020 on Capitol Hill in Washington.On Thursday, a bipartisan group of senators introduced legislation aiming to help the U.S. government develop more technology partnerships with allies to counter China’s rise in artificial intelligence, 5G, quantum computing and other areas.The bill, led by Virginia Democratic Senator Mark Warner, a former technology entrepreneur, would create a new interagency office within the State Department focusing on coordinating tech strategies with other democratic nations. It would also create a $5 billion fund supporting research projects between government and private companies.In this image from video, Senate Minority Leader Chuck Schumer of N.Y., speaks in the U.S. Capitol on Jan. 6, 2021.Last week, Senate Majority Leader Chuck Schumer urged a bipartisan effort to draft a bill investing in disruptive new technologies to challenge China.Also last week, President Joe Sen. Bob Menendez, D-N.J., talks to reporters on Capitol Hill in Washington on June 12, 2018.Democratic Senator Bob Menendez of New Jersey, chairman of Senate Foreign Relations Committee, told VOA Mandarin he believes the bill will receive broad bipartisan support.“On the broad issue of China, supply chain is one element of it. But we are working on the broader issue of how do we both compete with China and how do we confront China,” Menendez said, “I think there’s plenty of room where there should be a common ground that we can come together.”He added that he has been discussing America’s China policy with Secretary of State Tony Blinken, and the State Department is conducting its own comprehensive evaluation on current China policies.“There’s a whole of government review vis-a-vis China, which I applaud,” Menendez told VOA.Similar efforts are ongoing in the U.S. Congress, where several Republican legislators are pushing the White House to maintain former President Donald Trump’s hardline posture on China.Rep. Greg Steube, R-Fla, speaks during a House Judiciary subcommittee hearing on Capitol Hill on July 29, 2020 in Washington.Representative Greg Steube, a Florida Republican, introduced the Keep Huawei on the Entity List Act on Wednesday, which would continue export controls and keep China’s telecommunication firm Huawei on the U.S. Department of Commerce’s entity list.“Huawei is one of the most powerful tools that the Chinese Communist Party can use for espionage and potential destruction against the United States,” Steube said in a statement.James Lankford, a Republican senator from Oklahoma, said that he and his colleagues have been talking with the White House about keeping some of the Trump-era policies on China.“We want to make it very clear. And that policy shouldn’t be thrown aside just because they have the name Trump in front of them,” he told VOA. “If there were good policies, and they were good policies, and they should remain.”Artificial intelligence for the futureThe artificial intelligence report recommends that the Department of Defense must have the foundations in place by 2025 for widespread adoption of artificial intelligence systems.The commission also addressed the ethics of using AI-enabled and autonomous weapons. For now, it said the Defense Department has adequate protections in place so that such weapons do not require a global ban and can continue to be used in accordance with international humanitarian law. It recommended establishing systems to build confidence in AI technology and keeping humans in the decision chain for deploying nuclear weapons.Lin Yang contributed to this report.
…
Confidence in COVID-19 vaccines is growing, with people’s willingness to have the shots increasing as they are rolled out across the world and concerns about possible side effects are fading, a 14-country survey showed on Friday.Co-led by Imperial College London’s Institute of Global Health Innovation (IGHI) and the polling firm YouGov, the survey found trust in COVID-19 vaccines had risen in nine out of 14 countries covered, including France, Japan and Singapore, which had previously had low levels of confidence.The latest update of the survey, which ran from Feb. 8-21, found that people in Britain are the most willing, with 77% saying they would take a vaccine designed to protect against COVID-19 if one was available that week.This is up from 55% in November, shortly before the first COVID-19 vaccine — co-developed by Pfizer- BioNTech — gained regulatory approval for use in Britain.People in France, Singapore and Japan remained among the least willing to have a COVID-19 vaccine, at 40%, 48% and 48%, respectively, but all three have seen confidence rising since November when only 25%, 36% and 39% of people were positive.The survey also found that worries over vaccine side effects have faded in the majority of countries, with fewer than half (45%) of all respondents currently reporting concern.Again, people in France, Singapore and Japan are currently most worried about side effects, with around six in 10 feeling concerned (56%, 59%, 61%), while Britain is the least concerned.The latest survey involved more than 13,500 people in Australia, Britain, Canada, Denmark, France, Germany, Israel, Italy, Japan, Netherlands, Norway, Singapore, South Korea, Spain and Sweden.
…